SBH
OPK icon

Segall Bryant & Hamill’s Opko Health OPK Stock Holding History

Segall Bryant & Hamill’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-13,696
Closed -$116K – 589
2013
Q4 		$116K Buy
+13,696
New +$138K ﹤0.01% 574

Other funds holding OPK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Segall Bryant & Hamill's OPK Position: Q1 2014 in Review

Segall Bryant & Hamill sold out of Opko Health (OPK) in Q1 2014, closing a stake of 13,696 shares — an estimated $116K sold.

Segall Bryant & Hamill first reported a position in OPK in Q4 2013 and held it in 1 quarter. The position peaked at $116K in Q4 2013. 168 funds tracked by Wall St. Rank hold OPK as of Q1 2014.

  • Segall Bryant & Hamill reported no remaining Opko Health position as of Q1 2014 after selling out during the quarter.
  • Segall Bryant & Hamill sold 13,696 Opko Health shares in Q1 2014, an estimated $116K.
  • Segall Bryant & Hamill first reported a position in Opko Health in Q4 2013 and held it in 1 quarter.
  • Segall Bryant & Hamill's Opko Health position peaked at $116K in Q4 2013.
  • 168 funds tracked by Wall St. Rank held Opko Health as of Q1 2014.

Based on Segall Bryant & Hamill's 13F filing for Q1 2014, filed 14 May 2014.